Degos L - Search Results

1

The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.

Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F, et al. Rousselot P, et al. Among authors: degos l. Oncogene. 1994 Feb;9(2):545-51. Oncogene. 1994. PMID: 8290265

2

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.

Koken MH, Daniel MT, Gianni M, Zelent A, Licht J, Buzyn A, Minard P, Degos L, Varet B, de Thé H. Koken MH, et al. Among authors: degos l. Oncogene. 1999 Jan 28;18(4):1113-8. doi: 10.1038/sj.onc.1202414. Oncogene. 1999. PMID: 10023688

3

Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients.

Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C. Cornic M, et al. Among authors: degos l. Cancer Res. 1992 Jun 15;52(12):3329-34. Cancer Res. 1992. PMID: 1317749

4

A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia.

Castaigne S, Balitrand N, de Thé H, Dejean A, Degos L, Chomienne C. Castaigne S, et al. Among authors: degos l. Blood. 1992 Jun 15;79(12):3110-5. Blood. 1992. PMID: 1375840 Free article.

5

The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. de Thé H, et al. Among authors: degos l. Cell. 1991 Aug 23;66(4):675-84. doi: 10.1016/0092-8674(91)90113-d. Cell. 1991. PMID: 1652369

6

All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.

Chomienne C, Balitrand N, Ballerini P, Castaigne S, de Thé H, Degos L. Chomienne C, et al. Among authors: degos l. J Clin Invest. 1991 Dec;88(6):2150-4. doi: 10.1172/JCI115547. J Clin Invest. 1991. PMID: 1661301 Free PMC article.

7

[Biological parameters of the efficiency of retinoic acid in acute leukemia].

Chomienne C, Cornic M, Castaigne S, Lefebvre P, de Thé H, Dejean A, Degos L. Chomienne C, et al. Among authors: degos l. C R Seances Soc Biol Fil. 1991;185(6):456-63. C R Seances Soc Biol Fil. 1991. PMID: 1822394 Review. French.

8

The PML growth-suppressor has an altered expression in human oncogenesis.

Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thépot J, Juhlin L, Degos L, Calvo F, de Thé H. Koken MH, et al. Among authors: degos l. Oncogene. 1995 Apr 6;10(7):1315-24. Oncogene. 1995. PMID: 7731682

9

Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.

Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martiat P, Degos L, Chen Z, et al. Guidez F, et al. Among authors: degos l. Leukemia. 1994 Feb;8(2):312-7. Leukemia. 1994. PMID: 8309256

10

Hairy cell leukemia: follow-up after completion of alpha interferon treatment.

Castaigne S, Sigaux F, Degos L, Flandrin G. Castaigne S, et al. Among authors: degos l. Nouv Rev Fr Hematol (1978). 1989;31(5):321-5. Nouv Rev Fr Hematol (1978). 1989. PMID: 2587199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters